Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours
1998

Assessing Drug Penetration in Tumors

publication Evidence: moderate

Author Information

Author(s): RM Phillips, PM Loadman, BP Cronin

Primary Institution: University of Bradford

Hypothesis

The study aims to evaluate the ability of various drugs to penetrate multicell layers in tumors.

Conclusion

The study found that poor drug penetration and rapid elimination in vivo contribute to the clinical failure of E09.

Supporting Evidence

  • E09 does not penetrate multicell layers effectively, which may explain its poor clinical outcomes.
  • Tirapazamine penetrates multicell layers more rapidly than doxorubicin.
  • Reducing oxygen tension decreases the rate of drug penetration.
  • Inclusion of dicoumarol increases the rate of E09 penetration.

Takeaway

This study looks at how well cancer drugs can get into the hard-to-reach parts of tumors, which is important for making them work better.

Methodology

DLD-1 human colon carcinoma cells were cultured on Transwell-COL plastic inserts, and drug penetration was assessed using high-performance liquid chromatography (HPLC).

Limitations

The study primarily focuses on in vitro conditions, which may not fully replicate in vivo tumor environments.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication